Frontlight ResearchEarly access
Huntington's disease trials in South Korea
2 of 2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
- Where
- Seoul
- Age
- 21 years to 70 years
- People
- 32 worldwide
- Run by
- Sarepta Therapeutics, Inc.
See details and how to joinNCT07536061 - Phase 3Taking peopleA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Where
- Busan, Daejeon, Dongjak Gu, Seoul
- Age
- 21 years to 70 years
- People
- 770 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00